Case study from @Medidata
Take a look at this case study from @Medidata who are supporting @SouthamptonCTU with the AGILE clinical trial platform #COVID19 #clinicaltrials https://t.co/BqhUshldwx
— AGILE (@LivAgile) October 16, 2020
Other posts
A “game-changing” antiviral pill that is part of the AGILE Coronavirus Drug Testing Initiative has been approved for use in the UK.
After a stringent review …
A new international trial to assess whether high doses of the antiparasitic drug nitazoxanide could help treat patients with COVID-19 has begun in South Africa.
Researchers …
LIVERPOOL, England, 20 April 2021 — The University of Liverpool, Liverpool School of Tropical Medicine, and the NIHR Southampton Clinical Trials Unit at the University …
People across the south are being asked to play their part in helping vital research into new COVID-19 treatments.
A ground-breaking clinical trial platform being led …
The AGILE drug testing platform has received a multi-million pound award from the UK government’s Department of Health and Social Care to fast track the …
GlaxoSmithKline and Vir Biotechnology have joined forces with researchers from the Universities of Liverpool and Southampton, who are leading an accelerated early phase trials platform …